Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular ...
20mon MSN
With Hims & Her's main source of growth set to be extinguished, Citi analysts said its full-year guidance appears ...
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
Hims & Hers (HIMS) stock took a steep dive, dropping more than 27%Tuesday morning — even after the millennial-focused ...
Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future ...
Yahoo Finance host Josh Lipton examines the top stories on Wall Street as part of today's Market Minute. Home Depot (HD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback